OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3284
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome is an extremely rare condition that was historically described in medical literature but has since been classified as obsolete in disease databases like Orphanet (code 3284). This means the condition may have been reclassified, merged with another diagnosis, or determined to no longer represent a distinct disease entity. The original description involved a combination of symptoms including a fast heart rate (tachycardia), high blood pressure (hypertension), abnormally small eyes (microphthalmos), and excess glycine in the urine (hyperglycinuria). These features together suggested a multi-system disorder affecting the heart, eyes, and metabolism. Because this condition is now considered obsolete, very little modern clinical data is available. It is possible that patients originally diagnosed with this syndrome would today receive a more specific or updated diagnosis based on current genetic and clinical knowledge. If you or a family member were given this diagnosis, it is strongly recommended to seek re-evaluation by a clinical geneticist who can apply modern diagnostic tools, including genetic sequencing, to determine whether a more precise diagnosis is available. Understanding the correct underlying condition is essential for guiding appropriate treatment and management.

Key symptoms:

Fast heart rate (tachycardia)High blood pressure (hypertension)Abnormally small eyes (microphthalmos)Excess glycine in the urine (hyperglycinuria)Possible vision problems due to small eye size

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome community →

No specialists are currently listed for OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome.

Start the conversation →

Latest news about OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome

No recent news articles for OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Since this syndrome is now considered obsolete, is there a more current diagnosis that fits my symptoms?,Would whole exome or whole genome sequencing help identify the underlying cause?,What is the best way to manage my blood pressure and heart rate long-term?,Are there any vision treatments or aids that could help with microphthalmos?,Should I see a metabolic specialist about the elevated glycine in my urine?,Are there any clinical trials or research studies I should know about?,What should I do in an emergency if my heart rate or blood pressure becomes dangerously high?

Common questions about OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome

What is OBSOLETE: Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome?

Tachycardia-hypertension-microphthalmos-hyperglycinuria syndrome is an extremely rare condition that was historically described in medical literature but has since been classified as obsolete in disease databases like Orphanet (code 3284). This means the condition may have been reclassified, merged with another diagnosis, or determined to no longer represent a distinct disease entity. The original description involved a combination of symptoms including a fast heart rate (tachycardia), high blood pressure (hypertension), abnormally small eyes (microphthalmos), and excess glycine in the urine (